CXCL8 and hypertrophic cardiomyopathy: “Group11” (Table S6D) merged as the third-biggest group composed of 3 BP-GO terms (regulation of response to wounding (GO:1903034), positive regulation of interleukin-8 production (GO:0032757) and positive regulation of type II interferon production (GO:0032729)) and 4 KEGG pathways (including African trypanosomiasis (KEGG:05143), Toxoplasmosis (KEGG:05145), Hypertrophic cardiomyopathy (KEGG:05410), and Viral protein interaction with cytokine and cytokine receptor (KEGG:04061)), involved in immune-related functions or diseases.